Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SEmi-OT: re lawyers' ethical conflicts in owning stocks....
 You say:

"what is our product???
we do not produce anything"

Our current product is IP.

The only thing we presently produce is MONEY. Lots of money. 

How much product would a company have to develop, produce, market and sell to achieve a similar finacial result?

I'll make it simpler still:

How much product would a company have to develop, produce, market and sell to achieve a similar finacial result to just the interest that can earned from the monies collected to date?

Even simpler:

How much product would a company have to develop, produce, market and sell to achieve a similar finacial result to the interest income that could be earned off the cash currently in PTSC's vault?

How much risk would have to be incurred to achieve the simplest of the above?

How fast could you make it happen? (as opposed to instantly using interest from cash on hand)?

While an alternate revenue stream (as we will soon be seeing from our low risk investment of small dollars in Holocom) is desireable, it isn't everything.  MONEY is everything. MONEY is the objective in any business.

JMHO,

SGE

Share
New Message
Please login to post a reply